U.S. flag

An official website of the United States government

NM_198056.2(SCN5A):c.[3694C>T;4859C>T] AND Brugada syndrome 1

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 4, 2000
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000009965.14

Alleles description [Variation Report for NM_198056.2(SCN5A):c.[3694C>T;4859C>T]]

NM_000335.5(SCN5A):c.3691C>T (p.Arg1231Trp)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.3691C>T (p.Arg1231Trp)
Other names:
p.R1232W:CGG>TGG
HGVS:
  • NC_000003.12:g.38566555G>A
  • NG_008934.1:g.88118C>T
  • NM_000335.5:c.3691C>TMANE SELECT
  • NM_001099404.2:c.3694C>T
  • NM_001099405.2:c.3694C>T
  • NM_001160160.2:c.3691C>T
  • NM_001160161.2:c.3532C>T
  • NM_001354701.2:c.3691C>T
  • NM_198056.3:c.3694C>T
  • NP_000326.2:p.Arg1231Trp
  • NP_001092874.1:p.Arg1232Trp
  • NP_001092875.1:p.Arg1232Trp
  • NP_001153632.1:p.Arg1231Trp
  • NP_001153633.1:p.Arg1178Trp
  • NP_001341630.1:p.Arg1231Trp
  • NP_932173.1:p.Arg1232Trp
  • LRG_289t1:c.3694C>T
  • LRG_289:g.88118C>T
  • NC_000003.11:g.38608046G>A
  • NM_198056.2:c.3694C>T
  • Q14524:p.Arg1232Trp
Protein change:
R1178W; ARG1232TRP
Links:
UniProtKB: Q14524#VAR_017679; OMIM: 600163.0004; dbSNP: rs199473207
NCBI 1000 Genomes Browser:
rs199473207
Molecular consequence:
  • NM_000335.5:c.3691C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.3694C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.3694C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160160.2:c.3691C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160161.2:c.3532C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.3691C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.3694C>T - missense variant - [Sequence Ontology: SO:0001583]

NM_000335.5(SCN5A):c.4856C>T (p.Thr1619Met)

Gene:
SCN5A:sodium voltage-gated channel alpha subunit 5 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p22.2
Genomic location:
Preferred name:
NM_000335.5(SCN5A):c.4856C>T (p.Thr1619Met)
HGVS:
  • NC_000003.12:g.38551513G>A
  • NG_008934.1:g.103160C>T
  • NM_000335.5:c.4856C>TMANE SELECT
  • NM_001099404.2:c.4859C>T
  • NM_001099405.2:c.4805C>T
  • NM_001160160.2:c.4760C>T
  • NM_001160161.2:c.4697C>T
  • NM_001354701.2:c.4802C>T
  • NM_198056.3:c.4859C>T
  • NP_000326.2:p.Thr1619Met
  • NP_001092874.1:p.Thr1620Met
  • NP_001092875.1:p.Thr1602Met
  • NP_001153632.1:p.Thr1587Met
  • NP_001153633.1:p.Thr1566Met
  • NP_001341630.1:p.Thr1601Met
  • NP_932173.1:p.Thr1620Met
  • NP_932173.1:p.Thr1620Met
  • LRG_289t1:c.4859C>T
  • LRG_289t2:c.4856C>T
  • LRG_289:g.103160C>T
  • NC_000003.11:g.38593004G>A
  • NM_000335.4:c.4856C>T
  • NM_198056.2:c.4859C>T
  • Q14524:p.Thr1620Met
Protein change:
T1566M; THR1620MET
Links:
UniProtKB: Q14524#VAR_017684; OMIM: 600163.0004; dbSNP: rs199473282
NCBI 1000 Genomes Browser:
rs199473282
Molecular consequence:
  • NM_000335.5:c.4856C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099404.2:c.4859C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001099405.2:c.4805C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160160.2:c.4760C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001160161.2:c.4697C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001354701.2:c.4802C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_198056.3:c.4859C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Brugada syndrome 1 (BRGDA1)
Synonyms:
Right bundle branch block, ST segment elevation, and sudden death syndrome
Identifiers:
MONDO: MONDO:0011001; MedGen: C4551804; Orphanet: 130; OMIM: 601144

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000030186OMIM
no assertion criteria provided
Pathogenic
(Jan 4, 2000)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Dumaine, R. Personal Communication. 2009. Quebec, Canada

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Genetic basis and molecular mechanism for idiopathic ventricular fibrillation.

Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q.

Nature. 1998 Mar 19;392(6673):293-6.

PubMed [citation]
PMID:
9521325

Cardiac Na(+) channel dysfunction in Brugada syndrome is aggravated by beta(1)-subunit.

Makita N, Shirai N, Wang DW, Sasaki K, George AL Jr, Kanno M, Kitabatake A.

Circulation. 2000 Jan 4-11;101(1):54-60.

PubMed [citation]
PMID:
10618304

Details of each submission

From OMIM, SCV000030186.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In affected members of a family with Brugada syndrome (BRGDA1; 601144), a distinct form of idiopathic ventricular fibrillation, Chen et al. (1998) found an arg1232-to-trp (R1232W) and a thr1620-to-met (T1620M) mutation on the same chromosome with no mutation in the other chromosome, suggesting to them that IVF in this family was inherited as an autosomal dominant trait. The presence of both normal and mutated sodium channels in the same tissue would promote heterogeneity of the refractory period, a well established mechanism in arrhythmogenesis, and therefore may be the underlying molecular defect that causes re-entrant arrhythmia in this family. The potential contribution of R1232W and T1620M mutations to the mechanism of IVF was determined by heterologous expression in Xenopus oocytes. They found that sodium channels with the missense mutation recovered from inactivation more rapidly than normal, indicating that IVF with right bundle branch block (RBBB) and ST segment elevation is a defect distinct from long QT syndrome. When studied alone, the R1232W mutant behaved most like normal channels, whereas the T1620M mutant closely followed the kinetic pattern of the double mutant. This indicated that T1620M is the mutation probably responsible for the IVF phenotype in this kindred and that R1232W could be a rare polymorphism. In summary, biophysical analysis of the 2 missense mutations in SCN5A showed a shift in the voltage dependence of steady-state inactivation toward more positive potentials associated with a 25 to 30% acceleration in recovery time from inactivation at potentials near -80mV.

Commenting that studies of the thr1620-to-met mutant by Chen et al. (1998) revealed an abnormal electrophysiologic profile at room temperature that did not adequately explain the ECG signature of Brugada syndrome, Dumaine et al. (1999) undertook a more detailed electrophysiologic study of the thr1620-to-met mutant protein. Dumaine et al. (1999) expressed the mutant protein in a mammalian cell line and employed a patch-clamp technique to study current kinetics at 32 degrees C. The results indicated that current decay kinetics were faster in mutant than in wildtype channels at this temperature and that recovery from inactivation was slower, with a significant shift in steady-state activation. These findings provided an explanation for the ECG features of Brugada syndrome and represented the first illustration of a cardiac sodium channel mutation in which arrhythmogenicity is revealed only at temperatures approaching the physiologic range.

Voltage-gated sodium channels are multimeric structures consisting of a large, heavily glycosylated alpha subunit and 1 or 2 smaller beta subunits. The beta subunits are thought necessary for normal gating function. In brain and skeletal muscle, the beta-1 subunit (600235) accelerates sodium channel inactivation. Makita et al. (2000) characterized the functional roles of the auxiliary beta subunit by coexpression of the beta subunit with either wildtype SCN5A or SCN5A carrying the heterologously expressed T1620M mutation in Xenopus oocytes. The midpoint of steady-state inactivation was significantly shifted to positive potentials in the T1620M alpha/beta-1 channel, with an acceleration in recovery from inactivation when compared to other channels. Makita et al. (2000) therefore suggested that coexpression of T1620M alpha/beta-1 subunits exposed a significant electrophysiologic deficit that may predispose to ventricular fibrillation. Expression of both normal and mutant channels, as in the hearts of patients with Brugada syndrome, would promote heterogeneity of the refractory period in their myocardium, which serves as an ideal electrical substrate for reentrant arrhythmia.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 20, 2024